Ann: FOD beverage & functional juice business growing at 25.9%, page-157

I'm not sure what to make of the 4C other than to say, more of the same BS with the exception of the Juice sales scan growth of ~25% which is impressive.

Whilst I admire it, I do not share your optimism Scherobi that FOD can achieve a positive full year NPAT. Their unaudited YTD EBITDA of ~$2.5M includes $1.5M from Q1 when coincidentally they launched Eridani and had an opening order with their 'related party' Careline for $1M. In terms of the quality of expected earnings, you might want to ask Tony about the provision for doubtful debts or expected credit loss on receivables of $1.86M in FY20 and $1.79M in FY19, also how much they have capitalised (taken to the balance sheet) for product development costs YTD in FY21 and not expensed to the P&L and while you're at it, it would be helpful to understand what the $500K intellectual property expense noted in their 4C (2.1(e)) relates to?

I'm willing to frame a market and take all bets #gamble responsibly, that FOD will report a negative NPAT (loss) for FY21 and add to their accumulated losses of (-$46M!)

Refinancing the Greensill debt is not straight forward and no bank is going to stand in their shoes. IMHO

Fortune favours the brave but not the uniformed. Demand more of the Board and its Directors.